APA (7th ed.) Citation

Weiss, K. H. (2017). Bis-choline tetrathiomolybdate in patients with Wilson's disease: An open-label, multicentre, phase 2 study. The lancet. Gastroenterology & Hepatology, 2(12), . https://doi.org/10.1016/S2468-1253(17)30293-5

Chicago Style (17th ed.) Citation

Weiss, Karl Heinz. "Bis-choline Tetrathiomolybdate in Patients with Wilson's Disease: An Open-label, Multicentre, Phase 2 Study." The Lancet. Gastroenterology & Hepatology 2, no. 12 (2017). https://doi.org/10.1016/S2468-1253(17)30293-5.

MLA (9th ed.) Citation

Weiss, Karl Heinz. "Bis-choline Tetrathiomolybdate in Patients with Wilson's Disease: An Open-label, Multicentre, Phase 2 Study." The Lancet. Gastroenterology & Hepatology, vol. 2, no. 12, 2017, https://doi.org/10.1016/S2468-1253(17)30293-5.